日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 study of pembrolizumab in patients with advanced rare cancers

帕博利珠单抗治疗晚期罕见癌症患者的二期研究

Naing, Aung; Meric-Bernstam, Funda; Stephen, Bettzy; Karp, Daniel D; Hajjar, Joud; Rodon Ahnert, Jordi; Piha-Paul, Sarina A; Colen, Rivka R; Jimenez, Camilo; Raghav, Kanwal P; Ferrarotto, Renata; Tu, Shi-Ming; Campbell, Matthew; Wang, Linghua; Sabir, Sarjeel H; Tapia, Coya; Bernatchez, Chantale; Frumovitz, Michael; Tannir, Nizar; Ravi, Vinod; Khan, Saria; Painter, Jeane M; Abonofal, Abulrahman; Gong, Jing; Alshawa, Anas; McQuinn, Lacey M; Xu, Mingxuan; Ahmed, Sara; Subbiah, Vivek; Hong, David S; Pant, Shubham; Yap, Timothy A; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E Ileana; Janku, Filip; Fu, Siqing; Simon, Richard M; Hess, Kenneth R; Varadhachary, Gauri R; Habra, Mouhammed Amir

Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines

鉴定癌细胞系中对基因毒性药物反应的药效学生物标志物和常见分子机制

Min, Dong-Joon; Zhao, Yingdong; Monks, Anne; Palmisano, Alida; Hose, Curtis; Teicher, Beverly A; Doroshow, James H; Simon, Richard M

D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files

D3Oncoprint:用于可视化和动态探索带注释基因组突变文件的独立软件

Palmisano, Alida; Zhao, Yingdong; Simon, Richard M

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions

磁共振/超声融合引导活检与标准扩展六分位活检在诊断磁共振可见病灶前列腺癌方面的效率比较

Siddiqui, M Minhaj; George, Arvin K; Rubin, Rachel; Rais-Bahrami, Soroush; Parnes, Howard L; Merino, Maria J; Simon, Richard M; Turkbey, Baris; Choyke, Peter L; Wood, Bradford J; Pinto, Peter A

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.

分析验证和应用靶向下一代测序突变检测分析方法在 NCI-MPACT 试验治疗分配中的应用

Lih Chih-Jian, Sims David J, Harrington Robin D, Polley Eric C, Zhao Yingdong, Mehaffey Michele G, Forbes Thomas D, Das Biswajit, Walsh William D, Datta Vivekananda, Harper Kneshay N, Bouk Courtney H, Rubinstein Lawrence V, Simon Richard M, Conley Barbara A, Chen Alice P, Kummar Shivaani, Doroshow James H, Williams Paul M

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer

比较磁共振/超声融合引导活检与超声引导活检在诊断前列腺癌中的应用

Siddiqui, M Minhaj; Rais-Bahrami, Soroush; Turkbey, Baris; George, Arvin K; Rothwax, Jason; Shakir, Nabeel; Okoro, Chinonyerem; Raskolnikov, Dima; Parnes, Howard L; Linehan, W Marston; Merino, Maria J; Simon, Richard M; Choyke, Peter L; Wood, Bradford J; Pinto, Peter A

Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance

基于多参数磁共振成像的列线图在前列腺癌主动监测中的临床意义

Siddiqui, M Minhaj; Truong, Hong; Rais-Bahrami, Soroush; Stamatakis, Lambros; Logan, Jennifer; Walton-Diaz, Annerleim; Turkbey, Baris; Choyke, Peter L; Wood, Bradford J; Simon, Richard M; Pinto, Peter A

Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies

双参数磁共振成像(MRI)作为前列腺特异性抗原(PSA)检测前列腺癌辅助手段在未行活检的男性患者中的诊断价值

Rais-Bahrami, Soroush; Siddiqui, M Minhaj; Vourganti, Srinivas; Turkbey, Baris; Rastinehad, Ardeshir R; Stamatakis, Lambros; Truong, Hong; Walton-Diaz, Annerleim; Hoang, Anthony N; Nix, Jeffrey W; Merino, Maria J; Wood, Bradford J; Simon, Richard M; Choyke, Peter L; Pinto, Peter A

GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials

GeneMed:一个用于协调支持精准肿瘤临床试验的下一代测序研究的信息中心

Zhao, Yingdong; Polley, Eric C; Li, Ming-Chung; Lih, Chih-Jian; Palmisano, Alida; Sims, David J; Rubinstein, Lawrence V; Conley, Barbara A; Chen, Alice P; Williams, P Mickey; Kummar, Shivaani; Doroshow, James H; Simon, Richard M

Is the "3+3" dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design

“3+3”剂量递增I期临床试验设计是否适用于治疗性癌症疫苗的研发?一种替代设计方案的建议

Rahma, Osama E; Gammoh, Emily; Simon, Richard M; Khleif, Samir N